|
|
||||||||
Letters |
1 Depts. of Lab. Med. & Pathobiol., Med. and Paediatr. (Genetics), Univ. of TorontoBanting Inst., Rm. 415, 100 College St., Toronto, ON M5G 1L5Canada
To the Editor:
Measurement of total plasma homocysteine (tHcy) can be a useful adjunct in the diagnosis of cobalamin or folate deficiency and is emerging as an independent predictor in many vaso-occlusive diseases (1). As clinical interest in this metabolite grows, the demand for simple and efficient methods of determination has increased. In some situations, a methionine-loading test may be conducted to evaluate homocysteine catabolism, but methionine is rarely measured concomitantly, because it usually requires a different assay methodology altogether. In homocystinuria caused by cystathionine beta-synthase deficiency, circulating methionine is often increased, whereas homocystinuria resulting from a relative deficiency of the remethylation pathway is characterized by hypomethioninemia (2).
In our previously reported serum assay for tHcy (3), we used the DX-500 Ion Chromatograph (Dionex Canada), outfitted with two pumps (in parallel), valves, and two columns (a 4 x 50 mm OmniPac PCX-500 precolumn and a 4 x 250 mm OmniPac PCX-500 analytical column) plumbed in series to permit "heart-cut" trapping of tHcy (4). However, with the ED40 electrochemical detector set for pulsed integrated amperometry (PIA) mode, any compound with a reduced sulfur atom, including methionine, will generate a signal proportional to concentration (5).
In our initial procedure, the disulfide reduction procedure with sodium borohydride (NaBH4) (6) was the most labor-intensive step and constituted a substantial source of assay error. Here, we report a simplified protocol for the tHcy assay that permits accurate simultaneous quantification of methionine.
As suggested by Gilfix et al. (7), we used tris(2-carboxyethyl)phosphine (TCEP) as a reductant instead of NaBH4. To 300 µL of plasma we added 30 µL of 100 g/L TCEP (Pierce Chemical Co.) and gently mixed with a rotating stirrer at room temperature for 30 min. Then, we added 1170 µL of mobile phase (150 mmol/L NaClO4, 100 mmol/L HClO4, and 50 mL/L CH3CN) and centrifuged the mix at 10 000g for 5 min. The supernatant was passed through a C18 solid-phase extraction cartridge, as described before (3), and 50 µL of filtrate was injected directly. Altering the valve-switch times to 1 min and 2 min generated a larger "heart-cut" of the eluting peaks, with homocysteine eluting at 7.9 min and methionine at 11.3 min.
With our plasma control, we found that TCEP reduction is complete
within a minute or so at room temperature (Fig. 1A
). Reduction of Hcy by borohydride at the same temperature was
still incomplete at 30 min, and even at 50 °C required at least 15
min to approach completion. Moreover, use of the TCEP reductant
significantly decreased between-run variation (CV = 3.1%, n
= 10, P <0.05, F test for comparison of
variances) in comparison with reduction of the same sample with
NaBH4 and use of our initial protocol (CV = 7.4%,
n = 10). Omission of the urea denaturant resulted in a 4%
increase of our target tHcy value for the control sample, but the
chromatographic profile without urea was less noisy and the assay
variation (within-run CV) was correspondingly decreased from 4.8%
(n = 16) to 3.8% (n = 16).
|
Assay of 58 patients' samples with a wide range of homocysteine values
(Fig. 1B
) showed excellent correlation (r =
0.96, Sy|x = 0.80), and
the line of best fit was not significantly different from the line of
identity: slope 0.947 (95% confidence interval 0.911.02);
y-intercept 0.23 (0.52 0.97). Analysis of residuals by a
runs test and examination of the BlandAltman plot (8)
revealed no significant nonlinear trends (Fig. 1B
, inset).
In evaluating our methionine assay, we found near-quantitative
recovery (98.4% ± 3.1%, n = 6) of 6.0 µmol/L reagent-grade
L-methionine added to a sample with a nominal methionine
concentration of 12.1 µmol/L. For 31 samples (Fig. 1C
), the
correlation between our method and conventional amino acid
chromatography with ninhydrin detection (Beckman 7300 Amino Acid
Analyzer) (9) was excellent (r =
0.96, Sy|x = 0.755). By
linear regression analysis, the line of best fit (y =
0.97x - 0.89) passed through the origin (95%
confidence interval for y-intercept: -0.71 to 2.5). Runs
test analysis of residuals and BlandAltman plot (Fig. 1C
, inset)
revealed no significant deviation from linearity. The within-run CV was
3.4% (n = 8) and the between-run CV was 4.3% (n = 6).
Although identical control sample aliquots were stored at -74 °C
and used only once, the measured methionine concentration showed a
noticeable downward drift, equivalent to a decrease of 1.6% per week.
Similar changes were observed with the calibrators. The susceptibility
of methionine to oxidation (forming methionine sulfoxide) is
well-described (10) and should be kept in mind when
interpreting plasma methionine data (11).
For our group, we found a mean ± SD plasma methionine concentration of 21.9 ± 2.4 µmol/L (range 18.326.5 µmol/L), which is within 3.5% of, and intermediate between, the means reported by Guttormsen et al. (22.7 ± 3.5 µmol/L, n = 12) (12) and Potgieter et al. (21.3 ± 2.1 µmol/L, n = 127) (11), who used phthalic aldehyde derivatization and fluorescence HPLC. Our results were also within 3.5% of the values obtained with the ninhydrin-based amino acid chromatography method (22.7 ± 0.35 µmol/L, n = 10) (13).
Our method simplifies the assay of tHcy and reduces assay time and cost. It may also enhance the assessment of methionine loading as a tool for the investigation of hyperhomocystinemia and the potential role of methionine as an antioxidant (14). It offers a rapid and simple alternative to the separate assay of methionine by conventional amino acid chromatography or tandem mass spectrometry (15) and is an attractive alternative to the simultaneous assay of homocysteine and methionine by GC-MS (16).
Acknowledgments
Supported by a grant from the Heart and Stroke Foundation of Ontario.
Footnotes
* Author and address for correspondence. Fax (416) 978-5650; e-mail davidec.cole{at}utoronto.ca
References
The following articles in journals at HighWire Press have cited this article:
![]() |
L. A Houghton, K. L Sherwood, R. Pawlosky, S. Ito, and D. L O'Connor [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 842 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Buono, L. J. Wykes, D. E. C. Cole, R. O. Ball, and P. B. Pencharz Regulation of Sulfur Amino Acid Metabolism in Men in Response to Changes in Sulfur Amino Acid Intakes J. Nutr., March 1, 2003; 133(3): 733 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Langman, J. G. Ray, J. Evrovski, E. Yeo, and D. E.C. Cole Hyperhomocyst(e)inemia and the Increased Risk of Venous Thromboembolism: More Evidence From a Case-Control Study Arch Intern Med, April 10, 2000; 160(7): 961 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E.C. Cole, H. J. Ross, J. Evrovski, L. J. Langman, S. E.S. Miner, P. A. Daly, and P.-Y. Wong Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients Clin. Chem., November 1, 1998; 44(11): 2307 - 2312. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |